Basic & Clinical Medicine ›› 2017, Vol. 37 ›› Issue (12): 1770-1773.
Previous Articles Next Articles
Received:
Revised:
Online:
Published:
Abstract: Heart failure as a common cause of a variety of cardiovascular disease and the main cause of death, early diagnosis and effective intervention is to improve the prognosis of patients and an important means of outcome. Galectin-3 is a new biomarker of myocardial fibrosis and heart failure in recent years. It plays a certain role in the diagnosis and treatment of heart failure.Galectin-3 plays a key role in ventricular remodeling and heart failure, which can be used as a new target for treatment of heart failure.
Key words: galectin-3, heart failure, ventricular remodeling, inflammatory, fibrosis.
CLC Number:
R541
0 / / Recommend
Add to citation manager EndNote|Reference Manager|ProCite|BibTeX|RefWorks
URL: http://journal11.magtechjournal.com/Jwk_jcyxylc/EN/
http://journal11.magtechjournal.com/Jwk_jcyxylc/EN/Y2017/V37/I12/1770